Fibrocytes: Discovery of a circulating connectivetissue cell progenitor

Fibrocytes: New Insights into Tissue Repair and Systemic Fibrosis

Volumn , Issue , 2007, Pages 1-18

  Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967669842     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812706690_0001     Document Type: Chapter

References (55)

1. Clark RAF. (1996) Wound repair: overview and general considerations. In: Clark RAF (ed.), The Molecular and Cellular Biology of Wound Repair, Plenum Press, New York, pp. 3-50.
2. Homer RJ, Elias JA. (2000) Consequences of long-term inflammation- airway remodeling. Clin Chest Med 21: 331-343.
3. Liu YH. (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217.
4. Coussens LM, Werb Z. (2002) Inflammation and cancer. Nature 420: 860-867.
5. Orimo A, Gupta PB, Sgroi DC, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
6. Dunphy J. (1963) The fibroblast - a ubiquitous ally for the surgeon. New Engl J Med 268: 1367-1377.
7. Stirling GA, Kakkar VV. (1969) Cells in the circulating blood capable of producing connective tissue. Br J Exper Pathol 50: 51-55.
8. Paget J. (1863), Lectures on Surgical Pathology, Longmans, London, pp. 1-848.
9. Cohnheim J. (1867) Ueber Entzundung und Eiterung (About inflammation and suppuration). Path Anat Physiol Klin Med 40: 1-79.
10. Fischer A. (1925) C.r. Seanc Soc Biol 92: 109.
11. Maximow AA. (1928) Arch exp Zellforsch 5: 169.
12. Allgower M, Hulliger L. (1960) Origin of fibroblasts from mononuclear blood cells: A study on in vitro formation of the collagen precursor, hydroxyproline, in buffy coat cultures. Surgery 47: 603-609.
13. Bucala R, Spiegel L, Chesney J, et al. (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
14. Brown J, Greaves M, Molgaard H. (1991) The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in hematopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 3: 175-184.
15. Schmidt M, Sun G, Stacey MA, et al. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171: 380-389.
16. Mori L, Bellini A, Stacey MA, et al. (2005) Fibrocytes contribute to the myofibroblast population inwoundedskin and originate fromthe bone marrow. Exper Cell Res 304: 81-90.
17. Fathke C, Wilson L, Hutter J, et al. (2004) Contribution of bone marrowderived cells to skin: collagen deposition and wound repair. Stem Cells 22: 812-822.
18. Opalenik SR, Davidson JM. (2005) Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 19: 1561-1563.
19. Abe R, Donnelly SC, Peng T, et al. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562.
20. Pilling D, Buckley CD, Salmon M, Gomer RH. (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171: 5537-5546.
21. Yang LJ, Scott PG, Giuffre J, et al. (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82: 1183-1192.
22. Labat ML, Bringuier AF, Arysphilippart C, et al. (1994) Monocytic origin of fibrosis - in vitro transformation of Hla-Dr monocytes into neofibroblasts- inhibitory effect of all-trans-retinoic acid on this process. Biomed Pharmacother 48: 103-111.
23. Fina L, Molgaard H, Robertson D, et al. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417-2426.
24. Barth PJ, Ramaswamy A, Moll R. (2002a) CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Archiv 441: 564-568.
25. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. (2002b) CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Archiv 440: 298-303.
26. Barth PJ, Ebrahimsade S, Hellinger A, et al. (2002c) CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Archiv 440: 128-133.
27. Hirohata S, Yanagida T, Nagai T, et al. (2001) Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukocyte Biol 70: 413-421.
28. Aiba S, Tagami H. (1997) Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutaneous Pathol 24: 65-69.
29. Aiba S, Tabata N, Ohtani H, Tagami H. (1994) CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol 130: 593-597.
30. Phillips RJ, Burdick MD, Hong K, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446.
31. Chesney J, Bacher M, Bender A, Bucala R. (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T-cells in situ. Proc Natl Acad Sci USA 94: 6307-6312.
32. Hashimoto N, Jin H, Liu TJ, et al. (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113: 243-252.
33. Moore BB, Kolodsick JE, Thannickal VJ, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684.
34. Chesney J, Metz C, Stavitsky A, et al. (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160: 419-425.
35. Hartlapp I, Abe R, Saeed RW, et al. (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis. FASEB J 15: 2215-2224.
36. Balmelli C, Ruggli N, McCullough K, Summerfield A. (2005) Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukocyte Biol 77: 923-933.
37. Yang LJ, Scott PG, Dodd C, et al. (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Reg 13: 398-404.
38. Gabbiani G. (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
39. Chauhan H, Abraham A, Phillips JRA, et al. (2003) There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 56: 271-276.
40. Ramaswamy A, Moll R, Barth PJ. (2003) CD34+ fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Archiv 443: 536-540.
41. Kirchmann TTT, Prieto VG, Smoller BR. (1994) CD34 staining pattern distinguishes basal-cell carcinoma from trichoepithelioma. Arch Dermatol 130: 589-592.
42. Barth PJ, Schweinsberg TSZ, Ramaswamy A, Moll R. (2004) CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Archiv 444: 231-234.
43. Naftzger C, Mule JJ, Bucala R, Rice G. (1998) Cell process optimization of fibrocytes, a novel antigen presenting cell. Society for Biological Therapy.
44. Naftzger C, Mule J, Redman B, et al. (1998) Fibrocytes are a novel antiogen presenting cell for autologous anti-cancer therapy. Cancer Vaccine Meeting, NY.
45. Zhu YD, Koo K, Bradshaw JD, et al. (2000) Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses. J Med Primatol 29: 182-192.
46. Grab DJ, Lanners HN, Martin LN, et al. (1999) Interaction of Borrelia burgdorferi with peripheral blood fibrocytes, antigen-presenting cells with the potential for connective tissue targeting. Molec Med 5: 46-54.
47. Grab DJ, Salim M, Chesney J, et al. (2002) A role for peripheral blood fibrocytes in Lyme disease? Med Hypoth 59: 1-10.
48. Grab DJ, Lanners HN, Williams WL, Bucala R. (1999) Peripheral blood fibrocytes with foamy virus infection-like morphology. Hum Pathol 30: 1395-1396.
49. Grab DJ, Salem ML, Dumler JS, Bucala R. (2004) Arole for the peripheral blood fibrocyte in leishmaniasis? Trends Parasitol 20: 12.
50. White B. (2001) Systemic sclerosis and related syndromes, epidemiology, pathology, and pathogenesis. In: Klippel J (ed.), Primer on the Rheumatic Diseases, Arthritis Foundation, Atlanta, pp. 354-357.
51. Cowper S, Su L, Bhawan J, et al. (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23: 383-393.
52. Cowper SE, Bucala R, Leboit PE. (2005) Case 35-2004: Nephrogenic fibrosing dermopathy. N Engl J Med 352: 1723.
53. Cowper SE. (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15: 785-790.
54. Cowper SE, Bucala R. (2003) Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25: 358.
55. Quan T, Cowper S, Bucala R. (2006) The role of circulating fibrocytes in fibrosis. Curr Rheumatology Rep 8: 145-150.